Summary
Genetic Mitochondrial Disorders are diseases that are caused by changes of loss of genes needed to make mitochondria and allow them to function normally. Mitochondria are found in most of our cells and produce most of the body’s energy, and these diseases can involve many organs, including the muscles, brain, heart, and liver. Symptoms such as muscle weakness, fatigue, developmental delays, seizures, hearing loss, vision loss, and problems with growth or coordination, among others, can occur. Mitochondrial disorder symptoms can range from mild to severe and may require lifelong care by multiple specialists. The gene changes that cause these disorders are usually inherited from one or both parents or occur spontaneously in a single person. For this reason, affected individuals may or may not have a family history, and the symptoms can change over time or become more pronounced as a child grows.
Description
- Genetic mitochondrial disorders occur when genes needed to make mitochondria are changed or lost
- These disorders may affect one organ system, or many parts of the body.
- There are numerous subtypes of genetic mitochondrial disorders including:
- Leigh syndrome
- MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes)
- MERRF (myoclonic epilepsy with ragged red fibers)
- Some children have mild symptoms; others have severe health problems.
- The conditions can be life-threatening, depending on which organs are affected.
Signs and Symptoms
- Diagnosis starts when doctors notice muscle weakness, tiredness, seizures, poor growth, or developmental delays.
- Common symptoms include:
- Weak muscles
- Poor balance and coordination
- Learning delays
- Hearing and vision problems
- Seizures
- Movement disorders
- Slower growth
- Symptoms may be sudden (acute) or long-term and slowly worsen over time.
- Symptoms can appear at any age, but many children show signs in infancy or early childhood.
Causes
- Most genetic mitochondrial disorders are hereditary—passed down as genetic changes from one or both parents.
- Sometimes, changes in genes happen randomly, without a family history.
- Nothing parents did caused these disorders.
- In some cases, doctors cannot find a clear cause even after testing.
Laboratory Investigations
- Tests may include:
- Genetic testing (gold standard)
- Blood and urine tests to check for chemical changes
- MRI scans and other imaging to see which organs are affected
- Very rarely, biopsy of different tissues may be helpful
- Some tests may be repeated to follow changes or monitor treatment effects for some patients.
Treatment and Therapies
- There is no cure, but symptoms can be managed with treatment. For a very small number of genetic mitochondrial diseases, there are recently FDA approved therapies that a doctor will prescribe.
- Treatment options may include:
- Medications for seizures, movement disorders, or heart problems, etc.
- Vitamins or supplements may be considered depending on specific diagnosis
- Physical therapy and occupational therapy
- Nutrition advice and feeding support
- The best treatment depends on severity and symptoms and is adjusted over time.
- It's important to talk to your doctor about side effects and choices.
- Treating symptoms may help children feel better and function more independently.
Outlook
- Prognosis depends on which body systems are affected and how severe the condition is.
- Some children can live independently; others may need ongoing help and support.
- These conditions do not usually go away, but symptoms might get better or worse with time.
- School and family life may require changes, such as more rest periods or special educational supports.
- Diet and regular exercise may help manage symptoms but do not cure the disorder.
Resources
The links and resources included in this section are solicited directly from the community by the Child Neurology Foundation through a formal submission process. CNF reserves the right to remove entities at any time if information is deemed inappropriate or inconsistent with the mission, vision, and values of CNF. The authors listed on this page have not endorsed the resources or links provided in this section.
MitoAction’s mission is to improve the quality of life for children, adults, and families living with mitochondrial disease through support, education, outreach, advocacy, clinical research initiatives and by granting wishes for children affected by mitochondrial disease.
To do this, MitoAction’s goals include:
- To improve quality of life for adults and children affected by mitochondrial disease.
- To internationally raise awareness about mitochondrial disorders, and their relationship to other diseases.
- To provide specific and practical materials that help patients to manage their symptoms
- To aggregate and connect the international mitochondrial disease community
- To engage pharmaceutical industry working toward therapeutic approaches to mitochondrial disorders.
- To create tools which empower patients and caregivers to be advocates for themselves or their children.
- To create unique experiential opportunities for adults and children affected by mitochondrial disease.
United Mitochondrial Disease Foundation
Mission of UMDF
To promote research and education for the diagnosis, treatment and cure of mitochondrial disorders and to provide support to affected individuals and families.
Our mission is to unite the global Leigh syndrome community to accelerate patient-centered research, treatments, and cures.
Research
ClinicalTrials.gov for Mitochondrial Conditions (birth to 17 years)
These are clinical trials that are recruiting or will be recruiting. Updates are made daily, so you are encouraged to check back frequently.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. This is a resource provided by the U.S. National Library of Medicine (NLM), which is an institute within the National Institutes of Health (NIH). Listing a study does not mean it has been evaluated by the U.S. Federal Government. Please read the NLM disclaimer for details.
Before participating in a study, you are encouraged to talk to your health care provider and learn about the risks and potential benefits.
For more information about participation in clinical trials, check out our education hub on the topic here.
The information in the CNF Child Neurology Disorder Directory is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
References
- DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348(26):2656-68.
- Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015;17(9):689-701.
- United Mitochondrial Disease Foundation. Mitochondrial Disease Overview.
- National Institute of Neurological Disorders and Stroke. Mitochondrial Myopathies.
- Perplexity AI, Inc. Perplexity [Internet]. San Francisco (CA): Perplexity AI, Inc.; 2025 [cited 2025 Oct 24]. Available from: https://www.perplexity.ai
This overview is for general information and is not a substitute for advice from your child's care team.
← Back to the Disorder Directory